The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More

The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
The Australian Therapeutic Goods Administration (TGA) has granted approval for Arrowhead Pharmaceuticals’ Redemplo (plozasiran), a novel therapeutic agent designed to…
Read More
A research team co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center…
Read More
The U.S. Food and Drug Administration (FDA) has granted approval to Axsome Therapeutics’ Auvelity (dextromethorphan HBr and bupropion HCl) for…
Read More
The advent of accessible home testing kits is significantly transforming the landscape of bowel cancer screening, making it more convenient…
Read More
The escalating demand for high-quality, structured data to fuel advanced Artificial Intelligence (AI) models, particularly Large Language Models (LLMs), has…
Read More
A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
A groundbreaking study, supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute, has revealed that…
Read More
In a landmark study that bridges four decades of biological mystery with cutting-edge structural chemistry, a research team led by…
Read More
A landmark study published in Science by researchers at The Rockefeller University (NY, USA) has unveiled the most comprehensive atlas…
Read More